Please enable JavaScript to continue using this application.

Compare $BRKR vs $RGEN | Chartloom

Compare

$BRKR vs $RGEN

Bruker Corp · Repligen Corp

BRKR

Bruker Corp

RGEN

Repligen Corp

Compare $BRKR vs $RGEN

Comparing Bruker Corp and Repligen Corp

BRKRBruker Corp

RGENRepligen Corp

BRKRBruker Corp

Market cap

$8.96B

P/E (TTM)

—

Forward P/E (NTM)

25.41x

Forward P/S (NTM)

2.43x

Rev growth (TTM)

1.6%

YTD performance

22.3%

52W performance

69.9%

FCF yield

0.7%

RGENRepligen Corp

Market cap

$9.81B

P/E (TTM)

237.08x

Forward P/E (NTM)

75.08x

Forward P/S (NTM)

10.82x

Rev growth (TTM)

16.5%

YTD performance

5.8%

52W performance

15.3%

FCF yield

1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

BRKR

RGEN

Detailed metrics comparison

BRKR

Bruker Corp

RGEN

Repligen Corp

Market Cap

BRKR$8.96B

RGEN$9.81B

Enterprise Value

BRKR$10.60B

RGEN$9.76B

Price

BRKR$58.84

RGEN$173.88

P/E Ratio

BRKRN/A

RGEN237.08x

P/S Ratio

BRKR2.56x

RGEN12.50x

EV/Sales

BRKR3.03x

RGEN12.43x

EV/EBITDA

BRKR19.99x

RGEN64.73x

P/B Ratio

BRKR4.05x

RGEN4.86x

P/FCF Ratio

BRKR138.23x

RGEN89.09x

EV/FCF

BRKR163.54x

RGEN88.59x

PEG Ratio

BRKRN/A

RGEN11.27x

Forward P/E (NTM)

BRKR25.41x

RGEN75.08x

Forward P/S (NTM)

BRKR2.43x

RGEN10.82x

Revenue (TTM)

BRKR$3.50B

RGEN$785M

Revenue Growth (YoY)

BRKR1.6%

RGEN16.5%

Forward Rev Growth

BRKR4.0%

RGEN17.6%

Gross Margin (TTM)

BRKR47.7%

RGEN53.8%

Operating Margin (TTM)

BRKR0.0%

RGEN6.5%

EBITDA Margin (TTM)

BRKR15.1%

RGEN18.8%

Net Margin (TTM)

BRKR-3.1%

RGEN5.3%

FCF Margin (TTM)

BRKR1.9%

RGEN14.0%

Net Income (TTM)

BRKR$-107M

RGEN$42M

FCF (TTM)

BRKR$65M

RGEN$110M

EPS (TTM)

BRKR-$0.70

RGEN$0.73

ROE (TTM)

BRKR-293.0%

RGEN2.0%

ROA (TTM)

BRKR-115.0%

RGEN1.4%

ROIC (TTM)

BRKR-167.0%

RGEN1.6%

Cash

BRKR$185M

RGEN$607M

Debt

BRKR$1.82B

RGEN$551M

Net Cash/Debt

BRKR$-1.64B

RGEN$56M

Current Ratio (TTM)

BRKR1.85x

RGEN9.05x

Quick Ratio (TTM)

BRKR0.88x

RGEN7.30x

Debt/Equity (TTM)

BRKR0.77x

RGEN0.26x

Debt/Assets (TTM)

BRKR0.0%

RGEN0.0%

Interest Coverage (TTM)

BRKRN/A

RGENN/A

Net Debt/EBITDA (TTM)

BRKR0.00x

RGEN0.00x

Beta

BRKR1.24

RGEN1.13

52W Performance

BRKR69.9%

RGEN15.3%

YTD Performance

BRKR22.3%

RGEN5.8%

% from 52W High

BRKR-12.2%

RGEN-12.6%

% from 52W Low

BRKR81.8%

RGEN72.2%

Asset Turnover (TTM)

BRKR0.56x

RGEN0.27x

FCF Yield (TTM)

BRKR0.7%

RGEN1.1%

Earnings Yield (TTM)

BRKR-1.2%

RGEN0.4%

Dividend Yield (TTM)

BRKR0.6%

RGENN/A

Rule of 40

BRKR3.5

RGEN30.5

EV/GP/RG

BRKR1.17

RGEN1.46

Ticker research

View BRKR research View RGEN research

Metric	BRKR Bruker Corp	RGEN Repligen Corp
Market & Valuation
Market Cap	$8.96B	$9.81B
Enterprise Value	$10.60B	$9.76B
Price	$58.84	$173.88
P/E Ratio	N/A	237.08x
P/S Ratio	2.56x	12.50x
EV/Sales	3.03x	12.43x
EV/EBITDA	19.99x	64.73x
P/B Ratio	4.05x	4.86x
P/FCF Ratio	138.23x	89.09x
EV/FCF	163.54x	88.59x
PEG Ratio	N/A	11.27x
Forward P/E (NTM)	25.41x	75.08x
Forward P/S (NTM)	2.43x	10.82x
Revenue & Growth
Revenue (TTM)	$3.50B	$785M
Revenue Growth (YoY)	1.6%	16.5%
Forward Rev Growth	4.0%	17.6%
Profitability
Gross Margin (TTM)	47.7%	53.8%
Operating Margin (TTM)	0.0%	6.5%
EBITDA Margin (TTM)	15.1%	18.8%
Net Margin (TTM)	-3.1%	5.3%
FCF Margin (TTM)	1.9%	14.0%
Net Income (TTM)	$-107M	$42M
FCF (TTM)	$65M	$110M
EPS (TTM)	-$0.70	$0.73
ROE (TTM)	-293.0%	2.0%
ROA (TTM)	-115.0%	1.4%
ROIC (TTM)	-167.0%	1.6%
Financial Health
Cash	$185M	$607M
Debt	$1.82B	$551M
Net Cash/Debt	$-1.64B	$56M
Current Ratio (TTM)	1.85x	9.05x
Quick Ratio (TTM)	0.88x	7.30x
Debt/Equity (TTM)	0.77x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.24	1.13
52W Performance	69.9%	15.3%
YTD Performance	22.3%	5.8%
% from 52W High	-12.2%	-12.6%
% from 52W Low	81.8%	72.2%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.27x
FCF Yield (TTM)	0.7%	1.1%
Earnings Yield (TTM)	-1.2%	0.4%
Dividend Yield (TTM)	0.6%	N/A
Other
Rule of 40	3.5	30.5
EV/GP/RG	1.17	1.46
Ticker research	View BRKR research	View RGEN research

Valuation

P/E Ratio

RGEN

237.08x

P/S Ratio

BRKR

2.56x

RGEN

12.50x

EV/FCF

RGEN

88.59x

BRKR

163.54x

Growth & revenue

Revenue Growth TTM

RGEN

16.5%

BRKR

1.6%

Forward Revenue Growth

RGEN

17.6%

BRKR

4.0%

Profitability & performance

Gross Margin

RGEN

53.8%

BRKR

47.7%

ROE

RGEN

2.0%

BRKR

-293.0%

FCF Yield %

RGEN

1.1%

BRKR

0.7%

52-Week Performance

BRKR

69.9%

RGEN

15.3%

Detailed metrics comparison

BRKR

Bruker Corp

RGEN

Repligen Corp

Market Cap

BRKR$8.96B

RGEN$9.81B

Enterprise Value

BRKR$10.60B

RGEN$9.76B

Price

BRKR$58.84

RGEN$173.88

P/E Ratio

BRKRN/A

RGEN237.08x

P/S Ratio

BRKR2.56x

RGEN12.50x

EV/Sales

BRKR3.03x

RGEN12.43x

EV/EBITDA

BRKR19.99x

RGEN64.73x

P/B Ratio

BRKR4.05x

RGEN4.86x

P/FCF Ratio

BRKR138.23x

RGEN89.09x

EV/FCF

BRKR163.54x

RGEN88.59x

PEG Ratio

BRKRN/A

RGEN11.27x

Forward P/E (NTM)

BRKR25.41x

RGEN75.08x

Forward P/S (NTM)

BRKR2.43x

RGEN10.82x

Revenue (TTM)

BRKR$3.50B

RGEN$785M

Revenue Growth (YoY)

BRKR1.6%

RGEN16.5%

Forward Rev Growth

BRKR4.0%

RGEN17.6%

Gross Margin (TTM)

BRKR47.7%

RGEN53.8%

Operating Margin (TTM)

BRKR0.0%

RGEN6.5%

EBITDA Margin (TTM)

BRKR15.1%

RGEN18.8%

Net Margin (TTM)

BRKR-3.1%

RGEN5.3%

FCF Margin (TTM)

BRKR1.9%

RGEN14.0%

Net Income (TTM)

BRKR$-107M

RGEN$42M

FCF (TTM)

BRKR$65M

RGEN$110M

EPS (TTM)

BRKR-$0.70

RGEN$0.73

ROE (TTM)

BRKR-293.0%

RGEN2.0%

ROA (TTM)

BRKR-115.0%

RGEN1.4%

ROIC (TTM)

BRKR-167.0%

RGEN1.6%

Cash

BRKR$185M

RGEN$607M

Debt

BRKR$1.82B

RGEN$551M

Net Cash/Debt

BRKR$-1.64B

RGEN$56M

Current Ratio (TTM)

BRKR1.85x

RGEN9.05x

Quick Ratio (TTM)

BRKR0.88x

RGEN7.30x

Debt/Equity (TTM)

BRKR0.77x

RGEN0.26x

Debt/Assets (TTM)

BRKR0.0%

RGEN0.0%

Interest Coverage (TTM)

BRKRN/A

RGENN/A

Net Debt/EBITDA (TTM)

BRKR0.00x

RGEN0.00x

Beta

BRKR1.24

RGEN1.13

52W Performance

BRKR69.9%

RGEN15.3%

YTD Performance

BRKR22.3%

RGEN5.8%

% from 52W High

BRKR-12.2%

RGEN-12.6%

% from 52W Low

BRKR81.8%

RGEN72.2%

Asset Turnover (TTM)

BRKR0.56x

RGEN0.27x

FCF Yield (TTM)

BRKR0.7%

RGEN1.1%

Earnings Yield (TTM)

BRKR-1.2%

RGEN0.4%

Dividend Yield (TTM)

BRKR0.6%

RGENN/A

Rule of 40

BRKR3.5

RGEN30.5

EV/GP/RG

BRKR1.17

RGEN1.46

Ticker research

View BRKR research View RGEN research

Metric	BRKR Bruker Corp	RGEN Repligen Corp
Market & Valuation
Market Cap	$8.96B	$9.81B
Enterprise Value	$10.60B	$9.76B
Price	$58.84	$173.88
P/E Ratio	N/A	237.08x
P/S Ratio	2.56x	12.50x
EV/Sales	3.03x	12.43x
EV/EBITDA	19.99x	64.73x
P/B Ratio	4.05x	4.86x
P/FCF Ratio	138.23x	89.09x
EV/FCF	163.54x	88.59x
PEG Ratio	N/A	11.27x
Forward P/E (NTM)	25.41x	75.08x
Forward P/S (NTM)	2.43x	10.82x
Revenue & Growth
Revenue (TTM)	$3.50B	$785M
Revenue Growth (YoY)	1.6%	16.5%
Forward Rev Growth	4.0%	17.6%
Profitability
Gross Margin (TTM)	47.7%	53.8%
Operating Margin (TTM)	0.0%	6.5%
EBITDA Margin (TTM)	15.1%	18.8%
Net Margin (TTM)	-3.1%	5.3%
FCF Margin (TTM)	1.9%	14.0%
Net Income (TTM)	$-107M	$42M
FCF (TTM)	$65M	$110M
EPS (TTM)	-$0.70	$0.73
ROE (TTM)	-293.0%	2.0%
ROA (TTM)	-115.0%	1.4%
ROIC (TTM)	-167.0%	1.6%
Financial Health
Cash	$185M	$607M
Debt	$1.82B	$551M
Net Cash/Debt	$-1.64B	$56M
Current Ratio (TTM)	1.85x	9.05x
Quick Ratio (TTM)	0.88x	7.30x
Debt/Equity (TTM)	0.77x	0.26x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.24	1.13
52W Performance	69.9%	15.3%
YTD Performance	22.3%	5.8%
% from 52W High	-12.2%	-12.6%
% from 52W Low	81.8%	72.2%
Efficiency & Yields
Asset Turnover (TTM)	0.56x	0.27x
FCF Yield (TTM)	0.7%	1.1%
Earnings Yield (TTM)	-1.2%	0.4%
Dividend Yield (TTM)	0.6%	N/A
Other
Rule of 40	3.5	30.5
EV/GP/RG	1.17	1.46
Ticker research	View BRKR research	View RGEN research